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Context: People experiencing possible prodromal symp-
toms of psychosis have a very high risk of developing the
disorder, but it is not possible to predict, on the basis of
their presenting clinical features, which individuals will
subsequently become psychotic. Recent neuroimaging
studies suggest that there are volumetric differences be-
tween individuals at ultra-high risk (UHR) for psycho-
sis who later develop psychotic disorder and those who
do not. However, the samples examined to date have been
small, and the findings have been inconsistent.
Objective: To assess brain structure in individuals at
UHR for psychosis in a larger and more representative
sample than in previous studies by combining magnetic
resonance imaging data from 5 different scanning sites.
Design: Case-control study.
Setting: Multisite.
Participants: A total of 182 individuals at UHR and 167
healthy controls. Participants were observed clinically for
a mean of 2 years. Forty-eight individuals (26.4%) in the
UHR group developed psychosis and 134 did not.
Main Outcome Measures: Magnetic resonance im-
ages were acquired from each participant. Group differ-
ences in gray matter volume were examined using opti-
mized voxel-based morphometry.
Results: The UHR group as a whole had less gray mat-
ter volume than did controls in the frontal regions bilat-
erally. The UHR subgroup who later developed psycho-
sis had less gray matter volume in the left parahippocampal
cortex than did the UHR subgroup who did not.
Conclusions: Individuals at high risk for psychosis show
alterations in regional gray matter volume regardless of
whether they subsequently develop the disorder. In the
UHR population, reduced left parahippocampal volume
was specifically associated with the later onset of psy-
chosis. Alterations in this region may, thus, be crucial
to the expression of illness. Identifying abnormalities that
specifically predate the onset of psychosis informs the
development of clinical investigations designed to pre-
dict which individuals at high risk will subsequently de-
velop the disorder.
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P SYCHOTIC DISORDERS AREusually preceded by a pro-dromal phase in which thereis a gradual deterioration ofglobal and social functioning
and the emergence of attenuated psy-
chotic symptoms.1,2 However, not all
people with these features progress to
develop a full-blown psychotic disorder;
20% to 50% develop psychosis, usually
within 24 months, but the remainder do
not.3-6 Individuals first seen with this
clinical syndrome are, thus, said to be at
ultra-high risk (UHR) for psychosis.7
Results of recent trials8-10 suggest that
clinical intervention in the UHR popula-
tion may reduce the risk of later transi-
tion to psychosis. However, it is difficult
on purely clinical grounds to distinguish
individuals who will later become psy-
chotic from those who will not.5,6,10 This
prevents the selective provision of poten-
tially preventive interventions to the sub-
groups most likely to become psychotic,
which is desirable from an ethical stand-
point and for the efficient use of health
care resources.
Recent studies11-20 using magnetic reso-
nance imaging (MRI) have examined
whether there are neuroanatomical dif-
ferences between UHR individuals who
subsequently develop psychosis and those
who do not. A variety of differences in re-
gional gray matter volume (GMV) have
Author Affiliations are listed at
the end of this article.
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been reported, but the findings have been inconsistent;
this may partly reflect the use of small samples. How-
ever, UHR individuals are hard to recruit, and it is diffi-
cult for any single center to scan a large sample. Sample
size is a particular problem for the key comparison be-
tween UHR individuals who later develop psychosis and
those who do not, which entails a further subdivision of
the UHR sample according to clinical outcome. A po-
tential solution is to conduct multicenter studies, with
the pooling of data to produce a relatively large total
sample. This approach has been successfully used in neu-
roimaging studies of other central nervous system dis-
orders in which patient recruitment is difficult.21,22
In the present study, whole-brain MRIs were ac-
quired from 5 MRI scanners in London, United King-
dom (2 sites); Basel, Switzerland; Munich, Germany; and
Melbourne, Australia. The objective was to identify the
most robust neuroanatomical abnormalities in individu-
als at UHR and to compare UHR participants who sub-
sequently made a transition to psychosis with those who
did not. At each site, participants were scanned at first
clinical presentation and were observed clinically for a
mean of 2 years so that they could then be subcatego-
rized according to clinical outcome. The MRI data from
each site were combined to form a large UHR sample,
which was subdivided into individuals who had devel-
oped psychosis (UHR-T) and those who had not (UHR-
NT). The MRI data from several matched healthy con-
trols were also acquired at each site.
The first prediction, based on data from previous stud-
ies,11,15,18,23-27 was that the UHR group as a whole would
show regional volumetric differences relative to con-
trols that were qualitatively similar to those seen in pa-
tients with schizophrenia. We then tested the main hy-
pothesis that UHR-T individuals would show differences
in GMV relative to UHR-NT individuals in the inferior
frontal, parahippocampal, and superior temporal corti-
ces, the areas most frequently implicated in previous stud-
ies. Critically, these predictions were based on the re-
sults of previous single-center studies11,15,18,23-27 that used
samples other than those reported in the present mul-
tisite investigation.
METHODS
SAMPLE
All the UHR individuals were recruited from specialized clini-
cal services for people at high risk for psychosis. Individuals
at UHR scanned at the 2 London sites (Institute of Psychiatry
and Maudsley Hospital) were recruited via Outreach and Sup-
port in South London (OASIS). Individuals at UHR scanned
in Basel were recruited through the clinic for early detection
of psychosis (FEPSY) at the Psychiatric Outpatient Depart-
ment, University Hospital. Those scanned in Munich were re-
cruited through the Early Detection and Intervention Centre
for Mental Crisis of the Department of Psychiatry and Psycho-
therapy, Ludwig-Maximilians-University. The UHR individu-
als scanned in Melbourne were recruited from the Personal As-
sessment and Crisis Evaluation (PACE) Clinic. Data were, thus,
combined from 5 MRI scanners at the Institute of Psychiatry,
the Maudsley Hospital, the University Hospital Basel, the Lud-
wig-Maximilians-University (Munich), and the Royal Mel-
bourne Hospital. Some of the data from London, Basel, Mu-
nich, and Melbourne have been described separately in previous
single-center studies.12-14,17,19,20,28-30 Data were from 182 pa-
tients at UHR.
All the UHR individuals at all the sites met the Personal As-
sessment and Crisis Evaluation criteria for UHR. Inclusion re-
quired the presence of 1 or more of the following features: (1)
“attenuated” psychotic symptoms, (2) brief limited intermit-
tent psychotic symptoms, or (3) a first-degree relative with a
psychotic disorder, plus a marked decline in social or occupa-
tional functioning.2,7 None of the participants met the criteria
for additional psychiatric disorders or learning disabilities. De-
tails of the inclusion and exclusion criteria and clinical char-
acteristics of the UHR individuals are reported in eTables 1, 2,
3, 4, 5, 6, and 7 (http://www.archgenpsychiatry.com). Most of
the UHR group (168 of 182 individuals [92.3%]) had never taken
antipsychotic agents or mood stabilizing drugs, and 14 (7.7%)
had been exposed to antipsychotic agents (mean [SD] expo-
sure time, 13.0 [19.3] months).
At each site, controls from the same geographic area as the
UHR individuals were recruited through local advertise-
ments. The control sample comprised 167 individuals and was
comparable with the total UHR group for sex, age, and race/
ethnicity. For all participants, the exclusion criteria were past
or present diagnosis of psychiatric illness, previous treatment
with antipsychotic drugs, medical illness, family history of psy-
chiatric illness, past or present diseases of the central nervous
system, alcohol or other substance abuse or dependence (de-
fined using DSM-IV criteria), and pregnancy (eTable 1).
During a mean (SD) of 30.6 (10.4) months of follow-up
subsequent to scanning, 48 of the UHR sample (26.4%)
developed psychosis (UHR-T) and 134 did not (UHR-NT).
Each site yielded a data set that included a UHR-T group, a
UHR-NT group, and a control group, except 1 of the London
data sets, from which the UHR-T group was too small (n=2)
to be included in the combined UHR-T vs UHR-NT compari-
son (eTable 8).
MRI ACQUISITION
At all 5 sites, volumetric MRIs were acquired using a T1-
weighted protocol. At 4 sites, the scanner field strength was 1.5
T, and at 1 site it was 3 T. Three sites used General Electric
scanners (Milwaukee, Wisconsin), and 2 used Siemens scan-
ners (Erlangen, Germany). The details of the MRI acquisition
sequence varied among scanners (eTable 9).
DATA ANALYSIS
Sociodemographic and Clinical Parameters
Differences in demographics and clinical profile between groups
were examined using 1-way analysis of variance for paramet-
ric data and a 2 test for nonparametric data using a commer-
cially available software program (SPSS, version 17.0 for Win-
dows; SPSS Inc, Chicago, Illinois) (Table 1).
Preprocessing
We examined group-related differences in GMV using voxel-
based morphometry, as implemented in SPM8 software (http:
//www.fil.ion.ucl.ac.uk/spm) running under MATLAB 7.1 (The
MathWorks, Inc, Natick, Massachusetts). First, T1-weighted
volumetric images were preprocessed using the DARTEL (dif-
feomorphic anatomical registration using exponentiated lie
algebra)31 SPM8 toolbox. This approach involves the creation
of a study-specific template and the segmentation of each in-
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dividual image using such a template, with the aim of maxi-
mizing accuracy and sensitivity.32 The following steps were fol-
lowed for voxel-based morphometry preprocessing: (1) checking
for scanner artifacts and gross anatomical abnormalities for each
subject, (2) setting the image origin to the anterior commis-
sure, (3) using the DARTEL toolbox to produce a high-
dimensional normalization protocol,31 (4) checking for homo-
geneity across the sample, and (5) using standard smoothing
(ie, 8 mm). A “modulation step” was also included in the nor-
malization to preserve the information about the absolute gray
matter values.33,34 After this preprocessing, we obtained
smoothed, modulated, normalized data that were used for the
statistical analysis.
STATISTICAL ANALYSIS
We performed 2 statistical analyses using SPM8 software. First,
an analysis of variance was used to compare gray matter im-
ages from UHR individuals (UHR-T and UHR-NT combined)
and controls. In this analysis, scanner site was modeled as a
factor, resulting in 10 experimental groups. Second, we per-
formed an analysis of variance to compare gray matter images
from UHR individuals who later became psychotic (UHR-T),
UHR individuals who did not become psychotic (UHR-NT),
and controls. In this analysis, scanner site was again modeled
as a factor, resulting in 14 experimental groups (1 UHR-T group
was too small for analysis [n=2] compared with the UHR-NT
group [n=19]; see previously herein). Including scanner site
as a factor in the statistical analysis allowed us to (1) model
scanner-related variance in the data, which had the effect of
reducing error variance and increasing statistical sensitivity, and
(2) examine the impact of scanner site by testing for scanner
effects and scanner group interactions. To assess how much
of the interindividual variance in regions that differed be-
tween UHR-T and UHR-NT was explained by diagnostic group
and scanner site, respectively, we used thep2 measure of effect
size in SPSS. In both analyses, we modeled age, sex, race/
ethnicity, and use of medication as covariates of no interest to
reduce the potential impact of these variables on the findings.
To identify regionally specific changes that were not con-
founded by global differences, we used the proportional scal-
ing option. Statistical inferences were made at P .05 after fami-
lywise error (FWE) correction, with an extent threshold of 5
voxels.
REGION-OF-INTEREST ANALYSES
In addition to the whole-brain analysis, regions of interest (ROIs)
were used to examine between-group differences in areas in
which volumetric abnormalities have previously been identi-
fied in studies of people at high risk for psychosis or patients
with first-episode psychosis.16,35,36 These ROIs were the left para-
hippocampal gyrus (MNI [Montreal Neurological Institute] co-
ordinates x, y, z, −23, 6, and −20),35 the right inferior frontal
gyrus (45, 37, and 0),36 and the left superior temporal gyrus
(−49, −31, and 2).16 We used the coordinates from the previ-
ous studies that had reported the most significant effects in these
regions; none of these previous studies had included data from
individuals who participated in the present investigation. Using
the SimpleROIBuilder toolbox (http://www.fil.ion.ucl.ac.uk
/spm/ext/), we created a mask that included the 3 chosen ROIs.
This mask consisted of 3 spheres with a radius of 8 mm cor-
responding to the 3 ROIs and a total of 758.71 voxels. Within
the mask, statistical inferences were made at P .05 after FWE
correction for multiple comparisons.
RESULTS
SOCIODEMOGRAPHIC AND
CLINICAL PARAMETERS
No statistically significant differences were noted among
the UHR-T, UHR-NT, and control groups in age, sex, total
GMV, and race/ethnicity (Table 1).
DIFFERENCES BETWEEN THE UHR AND
CONTROL GROUPS
The UHR group had less GMV than did controls (atP .05
after FWE correction) in 3 areas of the frontal cortex: the
medial orbital gyrus and the gyrus rectus bilaterally and
the right anterior cingulate gyrus (Figure 1 and
Table 2). In these regions, no significant effect of medi-
cation was noted even at trend level (P .05 uncor-
rected). There were no areas in which UHR individuals
had more GMV than did controls.
Table 1. Demographic Data and Global Brain Volumes of Study Samples
Characteristic
Healthy Controls
(n = 167)
UHR-T Group
(n = 48)
UHR-NT Group
(n = 134) Significance
Age, mean (SD), y 23.5 (4.2) 22.7 (4.5) 23.3 (5.3) F2 = 0.552
P = .58
Sex, No. 22 = 2.541
P = .28Male 104 15 51
Female 63 33 83
Race/ethnicity, No. 26 = 11.122
P = .09White 140 42 106
Black 11 1 7
Asian 10 0 6
Mixed 6 5 15
Handedness, No. 24 = 3.355
P = .50Right 147 44 126
Left 14 3 6
Ambidextrous 6 1 2
GMV, mean (SD), mm3 0.948 (0.11) 0.945 (0.08) 0.937 (0.10) F2 = 0.450
P = .64
Abbreviations: GMV, gray matter volume; UHR-NT, ultra-high risk without disease transition; UHR-T, ultra-high risk with disease transition.
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DIFFERENCES BETWEEN UHR INDIVIDUALS
WHO DID AND DID NOT DEVELOP PSYCHOSIS
Analysis by ROI revealed reduced gray matter volume in
the UHR-T group relative to the UHR-NT group in the
anterior part of the left parahippocampal gyrus (border-
ing the uncus) (MNI coordinates x=−21, y=6, and z=−27;
P =.03; z=3.35; and cluster size=6 voxels) (at P .05 af-
ter FWE correction) (Figure 2), where the difference
between UHR-T and UHR-NT accounted for 14% of the
total variance. In this region, no significant effect of medi-
cation was noted even at trend level (P .05 uncor-
rected). Plotting of gray matter values revealed that this
reduction was evident in each of the 4 sites examined for
this contrast (Figure 2). There were no significant dif-
ferences in the other ROIs (ie, in the right inferior fron-
tal gyrus and the left superior temporal gyrus).
To examine the predictive value of GMV in the left
parahippocampal gyrus, we extracted gray matter val-
ues from the peak voxel and performed a series of cross-
validation analyses using a predictive linear model in SPSS
software. This involved developing a predictive model
based on a data set from a single scanner site and testing
it in each of the other data sets; the average predictive
accuracy was 62% (sensitivity = 61% and specific-
ity=65%). We also performed a 3-fold cross-validation
analysis irrespective of scanner site that involved devel-
oping a predictive model based on two-thirds of the total
sample and testing it in the remaining one-third; this
yielded an average accuracy of 67% (sensitivity=68% and
specificity=66%).
COMMENT
We used MRI to study a large sample of UHR individu-
als created by pooling data from 5 sites. The UHR indi-
viduals were observed clinically subsequent to scanning
and were subcategorized according to which individu-
als developed psychosis and which did not.
On the basis of previous MRI studies of smaller UHR
samples collected at single sites,11,15,18,23-27 we first tested
the hypothesis that the UHR group as a whole would show
volumetric abnormalities relative to controls that were
qualitatively similar to those seen in patients with schizo-
phrenia. Consistent with this prediction, the UHR group
expressed significant reductions in GMV in the prefron-
tal and anterior cingulate cortices (P .05 after FWE cor-
rection), areas that have been consistently implicated in
volumetric neuroimaging studies of schizophrenia.37 In
contrast, we did not identify areas where there was more
GMV in the UHR sample than in controls.
The main prediction was that UHR individuals who
later developed psychosis would show differences in re-
gional GMV in the inferior frontal, parahippocampal, and
superior temporal cortices compared with those who did
not become psychotic. This hypothesis was, in part, con-
firmed: the UHR-T subgroup showed relatively reduced
GMV in the anterior part of the left parahippocampal gy-
rus, bordering the hippocampal uncus (P .05 after FWE
correction). In this area, there was less gray matter in
UHR-T individuals than in controls (P .05 corrected)
but no significant difference between the UHR-NT and
y = 40
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z = – 16 3
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Figure 1. Differences between the ultra-high-risk (UHR) and control (HC) groups. The images show the medial orbital region, where the total UHR sample showed
reduced gray matter volume relative to HCs (P .05 after familywise error correction).
Table 2. MNI Coordinates and z Scores for Regions Showing Differences in Gray Matter Volume Between the UHR and Healthy
Control Groupa
Healthy ControlUHR
Areab Hemisphere
MNI Coordinates Cluster
Size, No. of
Voxels z Score P Valuex y z
Medial orbital gyrus Right 7 40.5 −16.5 130 5.44 .001
Cingulate gyrus Right 12 58.5 9 50 5.35 .001
Medial orbital gyrus Left −18 52.5 −16.5 30 4.94 .005
Gyrus rectus Right 3 25.5 −25.5 73 4.94 .01
Gyrus rectus Left −4 25.5 −22.5 4.80 .02
Abbreviations: MNI, Montreal Neurological Institute; UHR, ultra-high risk.
aP  .05 after familywise error correction.
bNo clusters were detected for the UHRcontrol contrast.
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control groups (eTable 10). A series of cross-validation
analyses also revealed that GMV in this region allowed
discrimination between UHR-T and UHR-NT with an ac-
curacy of up to 67%. In contrast to some previous single-
center studies,16,36 we did not find statistically signifi-
cant differences in the inferior frontal and superior
temporal gyri.
Reductions in parahippocampal volume have been re-
ported in high-risk individuals relative to controls,36 as
have alterations in parahippocampal function.38 Over time,
reductions in parahippocampal volume have been de-
scribed in high-risk individuals with transient or iso-
lated psychotic symptoms,16 and longitudinal reduc-
tions have been described in high-risk individuals who
developed psychosis.15 Moreover, cross-sectional com-
parisons indicate that patients with first-episode psycho-
sis have smaller parahippocampal volumes than do con-
trols and UHR individuals.26 Meta-analyses suggest that
the parahippocampal region is one of the most robust sites
of volume reduction in chronic schizophrenia.37,39-41 Con-
temporary animal models of psychosis propose that al-
tered parahippocampal activity drives subcortical dopa-
mine dysfunction.42 These observations are consistent with
the notion that the parahippocampal cortex is critically
implicated in psychotic disorders.
At the time of scanning, the UHR-T and UHR-NT
groups were clinically indistinguishable; the volumetric
differences observed between them could be inter-
preted as neurobiological markers of an especially in-
creased vulnerability to psychosis or as early manifesta-
tions of a neuropathologic process underlying the
transition to psychosis. Because the data in the present
study were collected at a single cross-sectional time point,
we cannot determine at what stage these differences first
emerged. This issue could be addressed by longitudinal
neuroimaging studies of individuals at different time
points in the prodromal phase of psychosis.
A limitation of this study is that the data were col-
lected using different scanners and different acquisition
sequences.22,43,44 Nevertheless, we are confident that the
results do not represent an artifact due to the use of dif-
ferent scanners for several reasons. First, we sought to
control for these effects by using only MRI data col-
lected with T1-weighted sequences and by modeling scan-
ner site as an independent factor in the statistical analy-
sis. Second, a comparable proportion of controls,
nonconverters, and converters was scanned at each site,
except for 1 of the London data sets, which was, there-
fore, excluded from the UHR-T vs UHR-NT compari-
son. Third, plotting of gray matter values suggested that
the differences between the UHR-T and UHR-NT groups
were evident not only across different centers but also
within each site and, therefore, cannot be explained by
interscanner differences (Figure 2). Fourth, when we ex-
amined the impact of scanner site, we found no evi-
dence of either scanner effects or scanner  group in-
teractions in regions that differed between groups, even
when lowering the statistical threshold to P .05 (un-
corrected). Fifth, this approach to the integration of mul-
tiscanner data in the same statistical model has been used
successfully in previous studies22,43-45 that also com-
bined different scanners and acquisition sequences; these
studies typically found that scanner differences were sub-
stantially less than group differences. Consistent with this,
y = 6 z = – 27
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Figure 2. Differences between ultra-high-risk (UHR) individuals who did (UHR-T) and did not (UHR-NT) develop psychosis. The UHR-T individuals had less gray
matter volume than did the UHR-NT individuals in the left parahippocampal gyrus, bordering the uncus (MNI [Montreal Neurological Institute] coordinates x, y,
and z: −21, 6, and −27, respectively). For visualization purposes, effects are displayed at P .05 uncorrected. The plot shows mean gray matter volumes for the 2
UHR subgroups at each site (x-axis:1 indicates London, United Kingdom; 2, Basel, Switzerland; 3, Munich, Germany; and 4, Melbourne, Australia); values on the
y-axis refer to cubic millimeters per voxel. Error bars represent SD.
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we found that scanner-related variance (11%) was less
than group-related variance (14%) in the left parahip-
pocampal region, which differed between the UHR-T and
UHR-NT groups. The impact of the use of different scan-
ners and acquisition sequences could be further con-
trolled for by scanning the same individuals at each site,
but this was not feasible in the present investigation.
Data from the present study suggest that in the fu-
ture it may be possible to use MRI to facilitate the pre-
diction of psychosis in those at high risk.46 This would
be particularly useful in the clinical management of in-
dividuals at UHR because it is difficult to predict which
individuals will go on to develop psychosis on the basis
of their clinical features.4 As a result, it is not possible to
focus the provision of clinical resources, such as puta-
tively preventive treatments,47 to the subgroup of UHR
individuals who will later become psychotic. Clinical ap-
plication of neuroimaging in this context requires the iden-
tification of predictive markers at an individual level,
whereas the present data represent group differences. Im-
age analysis methods that classify individuals according
to patterns of data associated with diagnostic categories
may provide a means of addressing this issue.48
In conclusion, UHR is associated with alterations in
regional GMV, and in this population, reductions in the
parahippocampal region may be specifically linked to the
later onset of psychosis. These findings suggest that neu-
roimaging data may facilitate the prediction of illness in
individuals at high risk for psychosis and may inform the
development of new interventions designed to delay or
prevent its onset.
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